FDA Seeks More Data on Blood Cancer Drug
Stock quotes in this article:
SPPI
Spectrum shares fell about 20% to $5.27 in light and early pre-market trading Monday, not unexpected given the recent run-up in the stock and the high hopes for Zevalin's speedy approval.
As I discussed in Friday's Biotech Stock Mailbag, Spectrum's share price has jumped from $2.50 to as high as $8 since May -- an increase that was likely a bit premature given the uncertainty over Zevalin's future sales.- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
Connect with TheStreet
 |
 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,414.14 | 1,114.05 | 2,237.66 | 36.82 |
Oil *
72.73
|
|
UP
85.25
|
UP
11.58
|
UP
25.97
|
UP
1.36
|
10 Yr
3.68%
SPDR Gold
106.95
|
|
+0.83%
|
+1.05%
|
+1.17%
|
+3.84%
|
Data delayed 20 minutes |
